• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

The Cutaneous Connection: Sleep Disturbances in Older Patients with AD

Podcast

Jonathan Silverberg, MD, the associate professor of dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC, joins us to discuss a poster from the December 2021 RAD conference.

Related Videos
Related Content
94% of Patients With Atopic Dermatitis Report Satisfaction With Baricitinib Treatment

94% of Patients With Atopic Dermatitis Report Satisfaction With Baricitinib Treatment

Article
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath

The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath

Podcast
Addressing Quality of Life Specifics Associated With Atopic Dermatitis and Skin of Color

Addressing Quality of Life Specifics Associated With Atopic Dermatitis and Skin of Color

Article
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

Podcast
FDA Accepts sNDA for Arcutis' Roflumilast Cream 0.15% for Atopic Dermatitis, Sets July 2024 PDUFA Date

FDA Accepts sNDA for Arcutis' Roflumilast Cream 0.15% for Atopic Dermatitis, Sets July 2024 PDUFA Date

Article
RPT193 Demonstrates Greater Improvements in Clinical Efficacy Endpoints vs Placebo in Atopic Dermatitis

RPT193 Demonstrates Greater Improvements in Clinical Efficacy Endpoints vs Placebo in Atopic Dermatitis

Article
© 2023 MJH Life Sciences

All rights reserved.